Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 162
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
COMPASS Pathways plc announces second quarter 2022 financial results and business...
MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Canadian Patent Grant Strengthens Small Pharma’s International Position
Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough...
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health...
Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A
Opening the Mushroom Pharmacopeia: The Case of Norbaeocystin
PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...
COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...
Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results
Load more
